Cadrenal Therapeutics, Inc. announced the formation of its Scientific Advisory Board (SAB) in support of the development of tecarfarin for the prevention of systemic thromboembolism, more commonly referred to as blood clots, of cardiac origin in patients with end-stage renal disease and atrial fibrillation (ESRD + AFib). Members of the Cadrenal SAB include: Christopher Bull Granger, MD, Professor of Medicine in the Division of Cardiology at Duke University, Director of Cardiac Care Unit for Duke University Medical Center, Member, Duke Clinical Research Institute (DCRI), Principal Investigator, ARISTOTLE TRIAL; Elaine Hylek, MD, MPH, Professor of Medicine at Boston University School of Medicine, Section Editor for Thrombosis and Haemostasis and the Director of the Thrombosis and Anticoagulation Service at Boston Medical Center, Member, Evans Center for Interdisciplinary Biomedical Research, Boston University, Associate Director of the Education and Training Division of the Boston University Clinical Translational Science Institute; Michael Gibson, MS, MD, CEO of not-for profit Baim/PERFUSE Research Institutes, Harvard University Professor Cardiologist at Beth Israel Deaconess Medical Center of Boston, Founder and Chairman WikiDoc.org; Richard Whitlock, MD, Cardiac Surgeon and Associate Professor at Population Health Research Institute, McMaster University Medical Center, Investigator, Population Health Research Institute; Sean Pokorney, MD, MBA, Designated as Principal Investigator, Cardiologist, electrophysiologist and researcher specializing in patients with ESRD and AFib, Assistant Professor of Medicine at Duke University and is a member of the Duke Clinical Research Institute, Co-Principal Investigator, RENAL-AF; Michael Lincoff, MD, Vice Chairman, Department of Cardiovascular Medicine, Cleveland Clinic, Director of Clinical Research, Lerner Research Institute; Wolfgang C. Winkelmayer, MD, MPH, ScD, Chief, Section of Nephrology and Professor of Medicine, Baylor College of Medicine, Director, Selzman Institute for Kidney Health at Baylor College of Medicine.